Synapse - Biostatistics Service

Results (21)

Predictors of response to radiation therapy and of progression to multiple myeloma in patients with solitary bone and extramedullary plasmacytomas

Meeting Abstract

Fregonese, B.; Imber, B.; Lee, J.; Zhang, Z.; Toumbacaris, N.; Yahalom, J.; Hajj, C.
Hematological Oncology (2023)

Fulltext@MSK | Save

Treatment outcomes of limited stage grade 3A follicular lymphoma

Meeting Abstract

Sarkar, R. R.; Lee, J.; Zhang, Z.; Zelenetz, A.; Salles, G.; Yahalom, J.; Imber, B.
Hematological Oncology (2023)

Fulltext@MSK | Save

Patterns of disease failure by response to induction therapy in a large cohort of patients with primary central nervous system lymphoma

Meeting Abstract

Tringale, K. R.; Yahalom, J.; Scordo, M.; White, C.; Zhang, Z.; Grommes, C.; Imber, B.
Hematological Oncology (2023)

Fulltext@MSK | Save

Evolving consolidation patterns and modern outcomes for a large longitudinal cohort of primary CNS lymphoma patients

Meeting Abstract

Imber, B. S.; Tringale, K.; White, C.; Zhang, Z.; Scordo, M.; Yahalom, J.; Grommes, C.
Hematological Oncology (2023)

Fulltext@MSK | Save

Long‐term follow-up of multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in previously untreated patients with CLL/SLL

Meeting Abstract

Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A. M.; Noy, A.; more...
Hematological Oncology (2023)

Fulltext@MSK | Save

Impact of response to systemic bridging therapy on clinical outcomes and cytokine profile in patients receiving CAR T‐cell therapy for aggressive B‐cell lymphoma

Meeting Abstract

Wills, B.; Shouval, R.; Flynn, J.; Devlin, S. M.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Lin, R. J.; Imber, B.; Parascondola, A.; more...
Hematological Oncology (2023)

Fulltext@MSK | Save

Clinical outcomes and the role of observation in early‐stage follicular lymphoma

Meeting Abstract

Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
Hematological Oncology (2021)

Fulltext@MSK | Save

Real‐world assessment of practice efficiency with the introduction of subcutaneous rituximab

Meeting Abstract

Matasar, M. J.; Qiu, A.; Shapouri, S.; Drill, E. N.; Schade, J.; Ravelo, A.; Ni, A.; To, T. M.; Dawson, K. L.
Hematological Oncology (2019)

Fulltext@MSK | Save

Allogeneic hematopoietic cell transplantation impacts on immune evasive mechanisms in relapsed/refractory diffuse large B‐cell lymphoma – A single center experience

Meeting Abstract

Sauter, C. S.; Lin, R. J.; Ho, C.; Devlin, S. M.; Maloy, M. A.; Perales, M.; Dahi, P. B.; Schoder, H.; Jakubowski, A. A.; Barker, J. N.; more...
Hematological Oncology (2019)

Fulltext@MSK | Save

Safety and early data from a phase II trial of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (Hl) and follicular lymphoma (FL)

Meeting Abstract

Sermer, D.; Vardhana, S.; Batlevi, C.; Hamilton, A.; Moskowitz, A.; Caron, P.; Moskowitz, C.; Matasar, M.; Biggar, E.; Leung, E.; more...
Hematological Oncology (2019)

Fulltext@MSK | Save